Healthmine

Healthmine Doubles Sales, Delivers Strong 2025 Care Gap Closure Results

Healthmine’s 2025 Performance Highlights Significant Improvements in Member Engagement and Care Gap Closure In the competitive landscape of health engagement, where measurable outcomes are paramount, Healthmine stands out. The company, known for driving quality, risk, and member experience improvements, has…

Read MoreHealthmine Doubles Sales, Delivers Strong 2025 Care Gap Closure Results
NaphCare

NaphCare Launches Innovative Jail-Based Competency Treatment Program in Nevada

NaphCare Partners with Washoe County Sheriff’s Office to Launch First-of-Its-Kind Program Why is the correctional system struggling to address the growing mental health crisis among detainees? NaphCare, a leading correctional healthcare company, is addressing this critical issue head-on. Partnering with…

Read MoreNaphCare Launches Innovative Jail-Based Competency Treatment Program in Nevada
Angelini

Angelini Pharma and Quiver Bioscience Collaborate to Advance Genetic Epilepsy Therapies

Partnership Aims to Uncover Novel Therapies for Developmental and Epileptic Encephalopathies Why is the discovery of new therapies for genetic epilepsies so critical? Angelini Pharma, part of the privately owned Angelini Industries, and Quiver Bioscience, a discovery technology and therapeutics…

Read MoreAngelini Pharma and Quiver Bioscience Collaborate to Advance Genetic Epilepsy Therapies
Synthekine

Synthekine Inc. Appoints John A. Orwin as Board Chair to Lead Clinical Expansion

Biotech Leader Takes Helm as Synthekine Advances Phase 2 Cancer Study In the rapidly evolving landscape of biotechnology, where precision and innovation are paramount, Synthekine Inc. is making a strategic move to solidify its position. The company, which specializes in engineered cytokine…

Read MoreSynthekine Inc. Appoints John A. Orwin as Board Chair to Lead Clinical Expansion
Pelage Pharmaceuticals

Pelage Pharmaceuticals Strengthens Leadership and Board with Strategic Appointments

Pelage Pharmaceuticals Appoints New Board Member and Promotes Key Executives In the competitive landscape of regenerative medicine, where innovative solutions for hair loss are increasingly in demand, Pelage Pharmaceuticals is making strategic moves to solidify its position. The company, a clinical-stage biotechnology…

Read MorePelage Pharmaceuticals Strengthens Leadership and Board with Strategic Appointments
Bristol Myers Squibb

Bristol Myers Squibb Advances Alpha-Thalassemia Treatment With Reblozyl

Positive Top-Line Results for Reblozyl in Alpha-Thalassemia Study Is the treatment landscape for alpha-thalassemia about to change? Bristol Myers Squibb has announced positive top-line results from an ongoing, ex-US, Phase 2 registrational study evaluating Reblozyl® (luspatercept-aamt) versus placebo for anemia in adults…

Read MoreBristol Myers Squibb Advances Alpha-Thalassemia Treatment With Reblozyl